ARQ 087, an oral pan-fibroblast growth factor receptor (FGFR) inhibito
- This topic has 0 replies, 1 voice, and was last updated 7 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
ARQ 087, an oral pan-fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced intrahepatic cholangiocarcinoma (iCCA) with FGFR2 genetic aberrations.
http://abstracts.asco.org/199/AbstView_199_190418.html
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.